secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2024-09-27T23:59:59+00:00
Accession:  0001493152-24-038462
Event type: debt
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma issues $33K convertible note; due March 2025, conversion at $0.0003
--------------------------------------------------------------------------------

- Issued convertible promissory note with $33,000 principal ($30,000 net) to GS Capital Partners, LLC.
- Conversion price set at $0.0003 per share, dropping to $0.0001 if stock trades below that for 5 consecutive days.
- Maturity March 25, 2025; 8% annual interest, increasing to 24% on default.
- Proceeds used for general working capital; prepayment options with premiums from 110% to 125% in first 180 days.
- Note issued under Regulation D as unregistered securities exempt under Section 4(a)(2) of Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224038462/0001493152-24-038462-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224038462/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-038462

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer